[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"biomarker:cdk6-gene":3},{"name":4,"total":5,"recruiting":5,"trials":6},"CDK6 Gene",5,[7,15,21,27,33],{"nct_id":8,"title":9,"phases":10,"status":12,"updated_at":13,"content_modified":14},"NCT03310879","Study of the CDK4\u002F6 Inhibitor Abemaciclib in Solid Tumors Harboring Genetic Alterations in Genes Encoding D-Type Cyclins or Amplification of CDK4 or CDK6",[11],"Phase 2","RECRUITING","2026-08-26T02:17:39.048487Z","2026-05-05T02:43:29.160779Z",{"nct_id":16,"title":17,"phases":18,"status":12,"updated_at":19,"content_modified":20},"NCT02523014","Vismodegib, FAK Inhibitor GSK2256098, Capivasertib, and Abemaciclib in Treating Patients With Progressive Meningiomas",[11],"2026-08-26T02:16:38.897933Z","2026-05-05T02:43:27.482521Z",{"nct_id":22,"title":23,"phases":24,"status":12,"updated_at":25,"content_modified":26},"NCT02896335","Palbociclib and Pembrolizumab In Central Nervous System Metastases",[11],"2026-08-26T02:18:38.865010Z","2026-07-24T01:27:14.926741Z",{"nct_id":28,"title":29,"phases":30,"status":12,"updated_at":31,"content_modified":32},"NCT05843253","Study of Ribociclib and Everolimus in HGG and DIPG or Ribociclib and Temozolomide in DHG, H3G34-mutant",[11],"2026-08-26T02:19:31.671303Z","2026-05-05T02:43:29.388169Z",{"nct_id":34,"title":35,"phases":36,"status":12,"updated_at":37,"content_modified":38},"NCT04040205","Abemaciclib for Bone and Soft Tissue Sarcoma With Cyclin-Dependent Kinase (CDK) Pathway Alteration",[11],"2026-08-26T02:18:07.037408Z","2026-05-05T02:43:28.417090Z"]